LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer

  • Authors:
    • Saki Matsui
    • Naofumi Kagara
    • Chieko Mishima
    • Yasuto Naoi
    • Masafumi Shimoda
    • Atsushi Shimomura
    • Kenzo Shimazu
    • Seung Jin Kim
    • Shinzaburo Noguchi
  • View Affiliations

  • Published online on: December 6, 2017     https://doi.org/10.3892/ol.2017.7535
Metrics: HTML 0 views | PDF 0 views
0

Abstract

Tumor‑specific promoter hypermethylation of large tumor suppressor, homolog 2 (LATS2), a tumor suppressor gene, has been investigated using methylation‑specific polymerase chain reaction (MSP) assays in different types of human cancer producing conflicting results. The aim of the present study was to evaluate the methylation status of the LATS2 promoter region using bisulfite sequencing with a next generation sequencer for breast cancer. In the 11 patients enrolled in the present study, the LATS2 promoter methylation index (MI) was uniformly high in tumor and normal tissues of the breast (median, 84.0 and 87.4%, respectively). The presence of LATS2 promoter hypermethylation was confirmed in isolated tumor cells and normal epithelial cells using the magnetic‑activated cell sorting method. In situ hybridization for LATS2 messenger RNA (mRNA) revealed that the mRNA expression of LATS2 was higher in normal epithelial cells, compared with tumor cells, however, it was not significantly associated with LATS2 MI. In 12 breast cancer cell (BCC) lines and two normal breast cell lines, the LATS2 promoter was uniformly hypermethylated with no correlation between the mRNA expression of LATS2 and the LATS2 MI. In addition, treatment of the BCC lines with a demethylating reagent had minimal effect on the mRNA expression of LATS2 in any of these cell lines. These results demonstrated that LATS2 hypermethylation was not involved in silencing the mRNA expression of LATS2 mRNA. The lower mRNA expression level of LATS2 in tumor cells, compared with normal epithelial cells, suggested the possible involvement of downregulation in the mRNA expression of LATS2 in the pathogenesis of breast cancer. Therefore, the conflicting results previously reported for LATS2 promoter methylation in different types of cancer, detected using MSP assays may be attributable to the low fidelity of the MSP assay.

Related Articles

Journal Cover

Print ISSN: 1792-1074
Online ISSN:1792-1082

2016 Impact Factor: 1.39
Ranked #68/217 Oncology
(total number of cites)

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Matsui, S., Kagara, N., Mishima, C., Naoi, Y., Shimoda, M., Shimomura, A. ... Noguchi, S. (1899). LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. Oncology Letters, 0, 0-0. https://doi.org/10.3892/ol.2017.7535
MLA
Matsui, S., Kagara, N., Mishima, C., Naoi, Y., Shimoda, M., Shimomura, A., Shimazu, K., Kim, S. J., Noguchi, S."LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer". Oncology Letters 0.0 (1899): 0-0.
Chicago
Matsui, S., Kagara, N., Mishima, C., Naoi, Y., Shimoda, M., Shimomura, A., Shimazu, K., Kim, S. J., Noguchi, S."LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer". Oncology Letters 0, no. 0 (1899): 0-0. https://doi.org/10.3892/ol.2017.7535